Aurobindo Pharma USA, Inc.
Caitlin Sane is a skilled professional with extensive experience in quality assurance and analytical testing within the pharmaceutical industry. Currently serving as Senior Associate II at Biogen since August 2022 and as Development Quality Assurance Manager at Aurobindo Pharma USA, Inc., since December 2020, Caitlin has a strong foundation in stability studies, protocol development, and data compilation, highlighted by previous roles at Glenmark Pharmaceuticals and The Ritedose Corporation. With a Bachelor’s degree in Chemistry from the University of South Carolina, Caitlin has demonstrated expertise in compliance with safety and cGMP guidelines, method validation, and the utilization of advanced analytical instrumentation throughout a progressive career.
This person is not in any teams
This person is not in any offices
Aurobindo Pharma USA, Inc.
2 followers
Aurobindo USA is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Since its first US ANDA approval in 2004, Aurobindo has expanded its portfolio to include more than 150 product families, representing a wide range of therapeutic categories. Aurobindo has been recognized as the fastest growing pharmaceutical company in 2012,* and in early 2013, thanks to the ongoing support of our customers, became one of the top 10 pharmaceutical companies, brand or generic, in terms of total prescriptions dispensed.**